Zorevunersen

DB16912InvestigationalGene Therapies

Zorevunersen: Overview.

Mechanism: Pharmacologically active on Sodium channel protein type 1 subunit alpha
Curator reviewed
Also known as: 18-Mer Antisense Oligonucleotide Complementary To SCN1A mRNA · Rna, (p-thio)(2'-o-(2-methoxyethyl))(a-g-m5u-m5u-g-g-a-g-m5c-a-a-g-a-m5u-m5u-a-m5u-m5c) · STK-001

Resolves to

Compound

Targets

What you can answer from here — as of March 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Zorevunersen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.